Personalised treatment for patients diagnosed with glioblastoma multiforme (GBM)
Work just published from our Queen Mary University of London research centre could pave the way for truly personalised treatment for patients diagnosed with glioblastoma multiforme (GBM). The team there has established an entirely new experimental research pipeline to analyse cells derived from brain tumour tissue and compare these with their putative cell of origin from the same patient. Using this powerful technique, they have been able to identify changes in the function of genes that occu... Read the full story